Curing fashion's reliance on leather with an eco-friendly plant-based alternative

Curing fashion’s reliance on leather with an eco-friendly plant-based alternative

Alt. Leather’s innovative green technology makes natural fibres mimic the 3D network structure of animal leathers. Credit: Alt. Leather As the material left the curing oven, the Alt. Leather team knew it had worked—what they held in their hands looked and felt just like leather. That moment marked a breakthrough for the Melbourne-based start-up, which…

Read More
From underdog to genius: Yale computer scientist Sun Huanbo returns to China

From underdog to genius: Yale computer scientist Sun Huanbo returns to China

From a former community college student to a Yale-affiliated researcher, Sun Huanbo’s academic journey defies convention. Now, the computer scientist has made another unexpected leap: returning to China as a rising star in robotics and haptics. In March 2025, Peking University’s school of engineering proudly announced his appointment as assistant professor, doctoral mentor and head…

Read More
Inequities in cardiovascular risk and lifestyle factors among individuals with developmental disabilities: evidence from Korea’s national health screening program

Inequities in cardiovascular risk and lifestyle factors among individuals with developmental disabilities: evidence from Korea’s national health screening program

Data sources We derived the study population from the National Health Insurance Service (NHIS) database. The NHIS provides mandatory health care coverage for nearly all Koreans (approximately 50 million people), including NHI enrollees (97%) and Medical Aid beneficiaries (3%), including emergency, inpatient, and outpatient care. The NHIS database contains socio-demographic data such as sex, age, residence,…

Read More
What if curing cancer could cost 99% less in China?

What if curing cancer could cost 99% less in China?

A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a therapy reserved for the ultra-rich. But Chinese biotech start-ups are aiming to change that – by designing cancer therapy for a fraction of the cost and also taking on Western pharmaceutical giants in the process. Beijing-based Likang…

Read More